𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial

✍ Scribed by Lars Lannfelt; Kaj Blennow; Henrik Zetterberg; Stellan Batsman; David Ames; John Harrison; Colin L Masters; Steve Targum; Ashley I Bush; Ross Murdoch; Janet Wilson; Craig W Ritchie


Book ID
114408989
Publisher
The Lancet
Year
2008
Tongue
English
Weight
194 KB
Volume
7
Category
Article
ISSN
1474-4465

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES